BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 24612159)

  • 1. Experience in IVIg therapy for selected women with recurrent reproductive failure and NK cell expansion.
    Ramos-Medina R; García-Segovia A; Gil J; Carbone J; Aguarón de la Cruz A; Seyfferth A; Alonso B; Alonso J; León JA; Alecsandru D; Meliá E; Carrillo de Albornoz E; Ordoñez D; Santillán I; Verdú V; Garcia Ruiz de Morales JM; López-Hoyos M; López Larios A; Sampalo A; Caballero P; Ortiz Quintana L; Fernández-Cruz E; Sánchez-Ramón S
    Am J Reprod Immunol; 2014 May; 71(5):458-66. PubMed ID: 24612159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin treatment increased live birth rate in a Spanish cohort of women with recurrent reproductive failure and expanded CD56(+) cells.
    Moraru M; Carbone J; Alecsandru D; Castillo-Rama M; García-Segovia A; Gil J; Alonso B; Aguarón A; Ramos-Medina R; Martínez de María J; Oliver-Miñarro D; Rodríguez-Mahou M; Ortega V; Caballero P; Meliá E; Vidal J; Cianchetta-Sivori M; Esteban C; Vargas-Henny L; Dale J; Ortiz-Quintana L; Fernández-Cruz E; Sánchez-Ramón S
    Am J Reprod Immunol; 2012 Jul; 68(1):75-84. PubMed ID: 22509929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased pregnancy rates after IVF/ET with intravenous immunoglobulin treatment in women with elevated circulating C56+ cells.
    Coulam CB; Goodman C
    Early Pregnancy (Cherry Hill); 2000 Apr; 4(2):90-8. PubMed ID: 11723539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decline in number of elevated blood CD3(+) CD56(+) NKT cells in response to intravenous immunoglobulin treatment correlates with successful pregnancy.
    van den Heuvel MJ; Peralta CG; Hatta K; Han VK; Clark DA
    Am J Reprod Immunol; 2007 Nov; 58(5):447-59. PubMed ID: 17922698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High levels of peripheral blood NK cells in women suffering from recurrent spontaneous abortion are reverted from high-dose intravenous immunoglobulins.
    Perricone R; Di Muzio G; Perricone C; Giacomelli R; De Nardo D; Fontana L; De Carolis C
    Am J Reprod Immunol; 2006 Mar; 55(3):232-9. PubMed ID: 16451358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does immunotherapy for treatment of reproductive failure enhance live births?
    Coulam CB; Acacio B
    Am J Reprod Immunol; 2012 Apr; 67(4):296-304. PubMed ID: 22340745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Intravenous immunoglobulin on Th1 and Th2 lymphocytes and improvement of pregnancy outcome in recurrent pregnancy loss (RPL).
    Ahmadi M; Abdolmohammadi-Vahid S; Ghaebi M; Aghebati-Maleki L; Afkham A; Danaii S; Abdollahi-Fard S; Heidari L; Jadidi-Niaragh F; Younesi V; Nouri M; Yousefi M
    Biomed Pharmacother; 2017 Aug; 92():1095-1102. PubMed ID: 28622710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NK cell frequency and cytotoxicity in correlation to pregnancy outcome and response to IVIG therapy among women with recurrent pregnancy loss.
    Ahmadi M; Ghaebi M; Abdolmohammadi-Vahid S; Abbaspour-Aghdam S; Hamdi K; Abdollahi-Fard S; Danaii S; Mosapour P; Koushaeian L; Dolati S; Rikhtegar R; Oskouei FD; Aghebati-Maleki L; Nouri M; Yousefi M
    J Cell Physiol; 2019 Jun; 234(6):9428-9437. PubMed ID: 30317625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intravenous immunoglobulin (IVIG) as treatment for recurrent pregnancy loss (RPL)].
    Sapir T; Carp H; Shoenfeld Y
    Harefuah; 2005 Jun; 144(6):415-20, 454, 453. PubMed ID: 15999561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated peripheral blood natural killer cells are effectively downregulated by immunoglobulin G infusion in women with recurrent spontaneous abortions.
    Kwak JY; Kwak FM; Ainbinder SW; Ruiz AM; Beer AE
    Am J Reprod Immunol; 1996 Apr; 35(4):363-9. PubMed ID: 8739455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy to improve pregnancy outcome in women with abnormal natural killer cell levels/activity and recurrent miscarriage or implantation failure: A systematic review and meta-analysis.
    Woon EV; Day A; Bracewell-Milnes T; Male V; Johnson M
    J Reprod Immunol; 2020 Nov; 142():103189. PubMed ID: 32889304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory T cells improve pregnancy rate in RIF patients after additional IVIG treatment.
    Ahmadi M; Abdolmohammadi-Vahid S; Ghaebi M; Aghebati-Maleki L; Dolati S; Farzadi L; Ghasemzadeh A; Hamdi K; Younesi V; Nouri M; Yousefi M
    Syst Biol Reprod Med; 2017 Dec; 63(6):350-359. PubMed ID: 29099629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is intravenous immunoglobulins (IVIG) efficacious in early pregnancy failure? A critical review and meta-analysis for patients who fail in vitro fertilization and embryo transfer (IVF).
    Clark DA; Coulam CB; Stricker RB
    J Assist Reprod Genet; 2006 Jan; 23(1):1-13. PubMed ID: 16421767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD3-CD56+CD16+ natural killer cells and improvement of pregnancy outcome in IVF/ICSI failure after additional IVIG-treatment.
    Heilmann L; Schorsch M; Hahn T
    Am J Reprod Immunol; 2010 Mar; 63(3):263-5. PubMed ID: 20064143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin G treatment increases live birth rate in women with recurrent miscarriage and modulates regulatory and exhausted regulatory T cells frequency and function.
    Jafarzadeh S; Ahmadi M; Dolati S; Aghebati-Maleki L; Eghbal-Fard S; Kamrani A; Behrad B; Roshangar L; Jadidi-Niaragh F; Yousefi B; Mehdipour M; Farzadi L; Yousefi M
    J Cell Biochem; 2019 Apr; 120(4):5424-5434. PubMed ID: 30326143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of immunologic abortion with low-dose intravenous immunoglobulin.
    Stricker RB; Steinleitner A; Bookoff CN; Weckstein LN; Winger EE
    Fertil Steril; 2000 Mar; 73(3):536-40. PubMed ID: 10689009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin inhibits natural killer cell activity in vivo in women with recurrent spontaneous abortion.
    Ruiz JE; Kwak JY; Baum L; Gilman-Sachs A; Beaman KD; Kim YB; Beer AE
    Am J Reprod Immunol; 1996 Apr; 35(4):370-5. PubMed ID: 8739456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated preconception CD56+ 16+ and/or Th1:Th2 levels predict benefit from IVIG therapy in subfertile women undergoing IVF.
    Winger EE; Reed JL; Ashoush S; El-Toukhy T; Ahuja S; Taranissi M
    Am J Reprod Immunol; 2011 Nov; 66(5):394-403. PubMed ID: 21623994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin G infusion treatment for women with recurrent spontaneous abortions and elevated CD56+ natural killer cells.
    Kwak JY; Kwak FM; Gilman-Sachs A; Beaman KD; Cho DD; Beer AE
    Early Pregnancy (Cherry Hill); 2000 Apr; 4(2):154-64. PubMed ID: 11723544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin G modulates peripheral blood Th17 and Foxp3(+) regulatory T cells in pregnant women with recurrent pregnancy loss.
    Kim DJ; Lee SK; Kim JY; Na BJ; Hur SE; Lee M; Kwak-Kim J
    Am J Reprod Immunol; 2014 May; 71(5):441-50. PubMed ID: 24645850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.